RE: ERP / COGNISION - I am surprised people here are wondering how Anavex might be involved with one comment saying, "they probably just joined in."
Cannot be further from the truth IMVHO.
Anavex CHOSE Neuronetrix for its A2-73 P2a trial for Alzh. (see Nov. 7,2014 press release). Their COGNISION system likely adapted symbiotically while working out a solution for Anavex - any lab grown AI system needs a real world application to mould itself into a commercially viable solution.
Now how on earth would obscure little Neuronetrix even start to cobble together a consortium of heavy hitters in neuro-space let alone have them sign them up for a standardization process for the future?
The key is successful VALIDATION of COGNISION in a trial to influence its outcome in an complex multifactorial indication that has seen ZERO trial success for ages. Needless to say it's required the help of influencers like Hampel, French and Anavex's other stellar SAB members, but they have all needed to sprinkle the SPICE(Dunes) of convincing trial outcomes (so far in their possession) to make heads turn.
So make no mistake - Anavex is very much driving this through its influencers in the field.
Analogy: Here in SoCal, we've had quite a few tremblers lately (as high as a shallow 7) and it's generated plenty of talk of "the big one" and also of the yellowstone caldera. A big one is always preceded by an increasing frequency and magnitude of quakes and I cannot help but remark how similar this ERP consortium formation is as one small step that heralds the big leap for mankind with AVXL's A2-73 in Alzheimers, a little more than a year away.
PS: BIIB is so 20th century.
Market Data 
Markets 
